Q1 2025 Holdings
Filed 2025-05-15 | 68 holdings | $115.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $41.8M | 685,192 | 36.3% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $7.5M | 66,000 | 6.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.4M | 263,400 | 3.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.1M | 332,974 | 3.6% |
| Biodesix Inc | COM | 09075X108 | $3.6M | 5,736,113 | 3.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.3M | 30,240 | 2.9% |
| Elutia Inc(ELUT) | COM | 05479K106 | $3.0M | 1,187,735 | 2.6% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.0M | 161,000 | 2.6% |
| Phreesia Inc(PHR) | COM | 71944F106 | $2.9M | 114,700 | 2.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.5M | 138,000 | 2.1% |
| Quidelortho Corp | COM | 74838J101 | $2.4M | 67,619 | 2.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.3M | 48,002 | 2.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $2.3M | 7,500 | 2.0% |
| Docgo Inc(DCGO) | COM | 256086109 | $2.3M | 864,062 | 2.0% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $2.2M | 52,200 | 1.9% |
| Harrow Health Inc(HROW) | COM | 415858109 | $1.9M | 72,910 | 1.7% |
| Masimo Corp(MASI) | COM | 574795100 | $1.9M | 11,280 | 1.6% |
| EQT Corporation(EQT) | COM | 26884L109 | $1.8M | 34,619 | 1.6% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $1.8M | 88,404 | 1.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.7M | 50,000 | 1.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.4M | 210,005 | 1.2% |
| Treace Medical Concepts Inc(TMCI) | COM | 89455T109 | $1.4M | 164,947 | 1.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.1M | 310,930 | 1.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $940.2K | 88,697 | 0.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $773.2K | 67,002 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $704.6K | 21,000 | 0.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $699.8K | 6,000 | 0.6% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $666.4K | 30,006 | 0.6% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $638.1K | 10,000 | 0.6% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $579.4K | 16,000 | 0.5% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $552.4K | 31,000 | 0.5% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $514.4K | 16,000 | 0.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $492.6K | 20,000 | 0.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $476.4K | 128,768 | 0.4% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $449.2K | 32,110 | 0.4% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $436.5K | 50,000 | 0.4% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $401.9K | 10,000 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $365.4K | 8,280 | 0.3% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $343.2K | 51,000 | 0.3% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $339.0K | 60,000 | 0.3% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $334.6K | 33,000 | 0.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $325.6K | 40,300 | 0.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $312.6K | 8,000 | 0.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $306.2K | 14,000 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $300.0K | 40,000 | 0.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $298.9K | 8,000 | 0.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $276.6K | 26,000 | 0.2% |
| Outset Medical Inc(OMGBP) | COM | 690145107 | $271.9K | 24,584 | 0.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $239.0K | 2,700 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $228.5K | 28,000 | 0.2% |